I am interested in understanding if it is possible to do the following:
Given a dataset of sequenced genomes (mutations, CNAs, etc.) with associated epigenetics data (over/under-expression, hyper/hypo-methyletion), select the epigenetic changes (e.g., met/HGF overxpression) that are likely persistent during tumor origination and development.
Crossing epigenetic data with mutations/CNAs is the easy part of the solution. I would be mostly interesting in selecting such epigenetic modifications for non-mutated genes.